Michelle C. Miller

机构：Novartis (United States) · ORCID：0000-0002-7860-5785

发表论文 94 篇 · 总被引 7101 次 · h-index 31

代表论文

• Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1 (2020 · Annals of Oncology · 被引 615)
• Phase III / IV , Randomized, Fifty‐Two –Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus (2021 · Arthritis & Rheumatology · 被引 106)
• Galectin-3 N-terminal tail prolines modulate cell activity and glycan-mediated oligomerization/phase separation (2021 · Proceedings of the National Academy of Sciences · 被引 69)
• Structural insight into the binding of human galectins to corneal keratan sulfate, its desulfated form and related saccharides (2020 · Scientific Reports · 被引 23)
• EMBRACE : One Small Story in Lupus—One Giant Challenge in Clinical Trials (2022 · ACR Open Rheumatology · 被引 16)
• Galectin-3-integrin α5β1 phase separation disrupted by advanced glycation end-products impairs diabetic wound healing in rodents (2025 · Nature Communications · 被引 14)